nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinblastine—JUN—liver cancer	0.263	1	CbGaD
Vinblastine—kidney cancer—liver cancer	0.214	0.509	CtDrD
Vinblastine—lung cancer—liver cancer	0.207	0.491	CtDrD
Vinblastine—ABCC6—Doxorubicin—liver cancer	0.0564	0.301	CbGbCtD
Vinblastine—ABCC1—Epirubicin—liver cancer	0.0313	0.167	CbGbCtD
Vinblastine—ABCB11—Doxorubicin—liver cancer	0.0234	0.125	CbGbCtD
Vinblastine—ABCC2—Sorafenib—liver cancer	0.0203	0.108	CbGbCtD
Vinblastine—ABCC1—Doxorubicin—liver cancer	0.0166	0.0888	CbGbCtD
Vinblastine—ABCB11—bile canaliculus—liver cancer	0.0162	0.342	CbGeAlD
Vinblastine—ABCC2—Doxorubicin—liver cancer	0.0123	0.0657	CbGbCtD
Vinblastine—ABCC2—bile canaliculus—liver cancer	0.00825	0.174	CbGeAlD
Vinblastine—ABCB1—Sorafenib—liver cancer	0.00662	0.0353	CbGbCtD
Vinblastine—CYP2D6—Sorafenib—liver cancer	0.00624	0.0333	CbGbCtD
Vinblastine—ABCB11—bile duct—liver cancer	0.00507	0.107	CbGeAlD
Vinblastine—ABCB1—Doxorubicin—liver cancer	0.00402	0.0214	CbGbCtD
Vinblastine—CYP3A4—Sorafenib—liver cancer	0.00397	0.0212	CbGbCtD
Vinblastine—ABCB11—bile—liver cancer	0.0039	0.0822	CbGeAlD
Vinblastine—CYP2D6—Doxorubicin—liver cancer	0.00378	0.0202	CbGbCtD
Vinblastine—ABCC2—bile duct—liver cancer	0.00258	0.0544	CbGeAlD
Vinblastine—CYP3A4—Doxorubicin—liver cancer	0.00241	0.0128	CbGbCtD
Vinblastine—ABCC2—bile—liver cancer	0.00198	0.0418	CbGeAlD
Vinblastine—Ischaemia—Sorafenib—liver cancer	0.00133	0.0917	CcSEcCtD
Vinblastine—TUBD1—embryo—liver cancer	0.00133	0.0281	CbGeAlD
Vinblastine—TUBA1A—gall bladder—liver cancer	0.00102	0.0215	CbGeAlD
Vinblastine—TUBA1A—embryo—liver cancer	0.000647	0.0136	CbGeAlD
Vinblastine—JUN—embryo—liver cancer	0.00064	0.0135	CbGeAlD
Vinblastine—TUBD1—liver—liver cancer	0.000615	0.013	CbGeAlD
Vinblastine—TUBE1—liver—liver cancer	0.000577	0.0122	CbGeAlD
Vinblastine—TUBB4A—embryo—liver cancer	0.000552	0.0117	CbGeAlD
Vinblastine—TUBG1—liver—liver cancer	0.000516	0.0109	CbGeAlD
Vinblastine—Neoplasm—Sorafenib—liver cancer	0.00044	0.0303	CcSEcCtD
Vinblastine—TUBB4B—embryo—liver cancer	0.000431	0.00909	CbGeAlD
Vinblastine—Myelosuppression—Epirubicin—liver cancer	0.000383	0.0264	CcSEcCtD
Vinblastine—Myelosuppression—Doxorubicin—liver cancer	0.000355	0.0244	CcSEcCtD
Vinblastine—ABCC6—liver—liver cancer	0.000353	0.00746	CbGeAlD
Vinblastine—ABCB11—liver—liver cancer	0.000317	0.00669	CbGeAlD
Vinblastine—TUBA1A—liver—liver cancer	0.000299	0.00631	CbGeAlD
Vinblastine—JUN—liver—liver cancer	0.000296	0.00625	CbGeAlD
Vinblastine—Acute coronary syndrome—Sorafenib—liver cancer	0.000268	0.0185	CcSEcCtD
Vinblastine—Myocardial infarction—Sorafenib—liver cancer	0.000267	0.0184	CcSEcCtD
Vinblastine—Neuropathy peripheral—Sorafenib—liver cancer	0.000267	0.0184	CcSEcCtD
Vinblastine—TUBB4A—liver—liver cancer	0.000256	0.00539	CbGeAlD
Vinblastine—Ileus—Epirubicin—liver cancer	0.000254	0.0175	CcSEcCtD
Vinblastine—Nystagmus—Epirubicin—liver cancer	0.000252	0.0173	CcSEcCtD
Vinblastine—Haemoglobin—Sorafenib—liver cancer	0.000245	0.0169	CcSEcCtD
Vinblastine—Haemorrhage—Sorafenib—liver cancer	0.000244	0.0168	CcSEcCtD
Vinblastine—Neuritis—Epirubicin—liver cancer	0.000241	0.0166	CcSEcCtD
Vinblastine—Ileus—Doxorubicin—liver cancer	0.000235	0.0162	CcSEcCtD
Vinblastine—TUBB—liver—liver cancer	0.000234	0.00493	CbGeAlD
Vinblastine—Nystagmus—Doxorubicin—liver cancer	0.000233	0.016	CcSEcCtD
Vinblastine—TUBB2A—liver—liver cancer	0.000232	0.0049	CbGeAlD
Vinblastine—TUBB6—liver—liver cancer	0.000229	0.00484	CbGeAlD
Vinblastine—Neuritis—Doxorubicin—liver cancer	0.000223	0.0153	CcSEcCtD
Vinblastine—Alopecia—Sorafenib—liver cancer	0.000216	0.0149	CcSEcCtD
Vinblastine—Extravasation—Epirubicin—liver cancer	0.000206	0.0142	CcSEcCtD
Vinblastine—TUBB4B—liver—liver cancer	0.000199	0.0042	CbGeAlD
Vinblastine—Rectal haemorrhage—Epirubicin—liver cancer	0.000199	0.0137	CcSEcCtD
Vinblastine—Cellulitis—Epirubicin—liver cancer	0.000198	0.0136	CcSEcCtD
Vinblastine—Anaemia—Sorafenib—liver cancer	0.000196	0.0135	CcSEcCtD
Vinblastine—Extravasation—Doxorubicin—liver cancer	0.000191	0.0131	CcSEcCtD
Vinblastine—Leukopenia—Sorafenib—liver cancer	0.00019	0.0131	CcSEcCtD
Vinblastine—Bone pain—Epirubicin—liver cancer	0.000188	0.0129	CcSEcCtD
Vinblastine—Rectal haemorrhage—Doxorubicin—liver cancer	0.000184	0.0127	CcSEcCtD
Vinblastine—Hypertension—Sorafenib—liver cancer	0.000183	0.0126	CcSEcCtD
Vinblastine—Cellulitis—Doxorubicin—liver cancer	0.000183	0.0126	CcSEcCtD
Vinblastine—Bone pain—Doxorubicin—liver cancer	0.000174	0.0119	CcSEcCtD
Vinblastine—Thrombocytopenia—Sorafenib—liver cancer	0.00017	0.0117	CcSEcCtD
Vinblastine—Anorexia—Sorafenib—liver cancer	0.000165	0.0114	CcSEcCtD
Vinblastine—Neoplasm—Epirubicin—liver cancer	0.000162	0.0112	CcSEcCtD
Vinblastine—ABCC2—liver—liver cancer	0.000161	0.0034	CbGeAlD
Vinblastine—Phlebitis—Epirubicin—liver cancer	0.000151	0.0104	CcSEcCtD
Vinblastine—Decreased appetite—Sorafenib—liver cancer	0.000151	0.0104	CcSEcCtD
Vinblastine—Neoplasm—Doxorubicin—liver cancer	0.00015	0.0103	CcSEcCtD
Vinblastine—Constipation—Sorafenib—liver cancer	0.000148	0.0102	CcSEcCtD
Vinblastine—Pain—Sorafenib—liver cancer	0.000148	0.0102	CcSEcCtD
Vinblastine—ABCC1—liver—liver cancer	0.000142	0.003	CbGeAlD
Vinblastine—Gastrointestinal pain—Sorafenib—liver cancer	0.000142	0.00976	CcSEcCtD
Vinblastine—Phlebitis—Doxorubicin—liver cancer	0.00014	0.00964	CcSEcCtD
Vinblastine—Abdominal pain—Sorafenib—liver cancer	0.000137	0.00944	CcSEcCtD
Vinblastine—Cerebrovascular accident—Epirubicin—liver cancer	0.000133	0.00916	CcSEcCtD
Vinblastine—Hypersensitivity—Sorafenib—liver cancer	0.000128	0.0088	CcSEcCtD
Vinblastine—ABCB1—embryo—liver cancer	0.000125	0.00264	CbGeAlD
Vinblastine—Asthenia—Sorafenib—liver cancer	0.000124	0.00857	CcSEcCtD
Vinblastine—Cerebrovascular accident—Doxorubicin—liver cancer	0.000123	0.00848	CcSEcCtD
Vinblastine—Diarrhoea—Sorafenib—liver cancer	0.000119	0.00817	CcSEcCtD
Vinblastine—Dizziness—Sorafenib—liver cancer	0.000115	0.0079	CcSEcCtD
Vinblastine—Vomiting—Sorafenib—liver cancer	0.00011	0.00759	CcSEcCtD
Vinblastine—Angina pectoris—Epirubicin—liver cancer	0.00011	0.00756	CcSEcCtD
Vinblastine—Headache—Sorafenib—liver cancer	0.000109	0.00748	CcSEcCtD
Vinblastine—Pancytopenia—Epirubicin—liver cancer	0.000107	0.00737	CcSEcCtD
Vinblastine—Nausea—Sorafenib—liver cancer	0.000103	0.00709	CcSEcCtD
Vinblastine—Angina pectoris—Doxorubicin—liver cancer	0.000102	0.00699	CcSEcCtD
Vinblastine—Pancytopenia—Doxorubicin—liver cancer	9.9e-05	0.00682	CcSEcCtD
Vinblastine—Neuropathy peripheral—Epirubicin—liver cancer	9.85e-05	0.00678	CcSEcCtD
Vinblastine—Agranulocytosis—Epirubicin—liver cancer	9.38e-05	0.00646	CcSEcCtD
Vinblastine—Neuropathy peripheral—Doxorubicin—liver cancer	9.12e-05	0.00627	CcSEcCtD
Vinblastine—Haemoglobin—Epirubicin—liver cancer	9.07e-05	0.00624	CcSEcCtD
Vinblastine—Haemorrhage—Epirubicin—liver cancer	9.02e-05	0.00621	CcSEcCtD
Vinblastine—Hypoaesthesia—Epirubicin—liver cancer	8.98e-05	0.00618	CcSEcCtD
Vinblastine—Pharyngitis—Epirubicin—liver cancer	8.95e-05	0.00616	CcSEcCtD
Vinblastine—Agranulocytosis—Doxorubicin—liver cancer	8.68e-05	0.00597	CcSEcCtD
Vinblastine—Haemoglobin—Doxorubicin—liver cancer	8.39e-05	0.00578	CcSEcCtD
Vinblastine—Haemorrhage—Doxorubicin—liver cancer	8.35e-05	0.00575	CcSEcCtD
Vinblastine—Hypoaesthesia—Doxorubicin—liver cancer	8.31e-05	0.00572	CcSEcCtD
Vinblastine—Pharyngitis—Doxorubicin—liver cancer	8.29e-05	0.0057	CcSEcCtD
Vinblastine—CYP3A4—liver—liver cancer	8.19e-05	0.00173	CbGeAlD
Vinblastine—CYP2D6—liver—liver cancer	8.06e-05	0.0017	CbGeAlD
Vinblastine—Alopecia—Epirubicin—liver cancer	7.97e-05	0.00549	CcSEcCtD
Vinblastine—Alopecia—Doxorubicin—liver cancer	7.38e-05	0.00508	CcSEcCtD
Vinblastine—Ill-defined disorder—Epirubicin—liver cancer	7.29e-05	0.00502	CcSEcCtD
Vinblastine—Anaemia—Epirubicin—liver cancer	7.26e-05	0.005	CcSEcCtD
Vinblastine—Malaise—Epirubicin—liver cancer	7.08e-05	0.00488	CcSEcCtD
Vinblastine—Vertigo—Epirubicin—liver cancer	7.06e-05	0.00486	CcSEcCtD
Vinblastine—Leukopenia—Epirubicin—liver cancer	7.03e-05	0.00484	CcSEcCtD
Vinblastine—Convulsion—Epirubicin—liver cancer	6.81e-05	0.00468	CcSEcCtD
Vinblastine—Hypertension—Epirubicin—liver cancer	6.78e-05	0.00467	CcSEcCtD
Vinblastine—Ill-defined disorder—Doxorubicin—liver cancer	6.74e-05	0.00464	CcSEcCtD
Vinblastine—Anaemia—Doxorubicin—liver cancer	6.72e-05	0.00462	CcSEcCtD
Vinblastine—Discomfort—Epirubicin—liver cancer	6.61e-05	0.00455	CcSEcCtD
Vinblastine—Malaise—Doxorubicin—liver cancer	6.55e-05	0.00451	CcSEcCtD
Vinblastine—Vertigo—Doxorubicin—liver cancer	6.53e-05	0.00449	CcSEcCtD
Vinblastine—Leukopenia—Doxorubicin—liver cancer	6.51e-05	0.00448	CcSEcCtD
Vinblastine—Convulsion—Doxorubicin—liver cancer	6.3e-05	0.00433	CcSEcCtD
Vinblastine—Thrombocytopenia—Epirubicin—liver cancer	6.28e-05	0.00432	CcSEcCtD
Vinblastine—Hypertension—Doxorubicin—liver cancer	6.27e-05	0.00432	CcSEcCtD
Vinblastine—Discomfort—Doxorubicin—liver cancer	6.11e-05	0.00421	CcSEcCtD
Vinblastine—Anorexia—Epirubicin—liver cancer	6.11e-05	0.00421	CcSEcCtD
Vinblastine—Thrombocytopenia—Doxorubicin—liver cancer	5.81e-05	0.004	CcSEcCtD
Vinblastine—ABCB1—liver—liver cancer	5.8e-05	0.00122	CbGeAlD
Vinblastine—Paraesthesia—Epirubicin—liver cancer	5.76e-05	0.00396	CcSEcCtD
Vinblastine—Anorexia—Doxorubicin—liver cancer	5.65e-05	0.00389	CcSEcCtD
Vinblastine—Decreased appetite—Epirubicin—liver cancer	5.57e-05	0.00384	CcSEcCtD
Vinblastine—Pain—Epirubicin—liver cancer	5.48e-05	0.00377	CcSEcCtD
Vinblastine—Constipation—Epirubicin—liver cancer	5.48e-05	0.00377	CcSEcCtD
Vinblastine—Paraesthesia—Doxorubicin—liver cancer	5.33e-05	0.00367	CcSEcCtD
Vinblastine—Feeling abnormal—Epirubicin—liver cancer	5.28e-05	0.00364	CcSEcCtD
Vinblastine—Gastrointestinal pain—Epirubicin—liver cancer	5.24e-05	0.00361	CcSEcCtD
Vinblastine—Decreased appetite—Doxorubicin—liver cancer	5.16e-05	0.00355	CcSEcCtD
Vinblastine—Constipation—Doxorubicin—liver cancer	5.07e-05	0.00349	CcSEcCtD
Vinblastine—Pain—Doxorubicin—liver cancer	5.07e-05	0.00349	CcSEcCtD
Vinblastine—Abdominal pain—Epirubicin—liver cancer	5.07e-05	0.00349	CcSEcCtD
Vinblastine—Feeling abnormal—Doxorubicin—liver cancer	4.89e-05	0.00336	CcSEcCtD
Vinblastine—Gastrointestinal pain—Doxorubicin—liver cancer	4.85e-05	0.00334	CcSEcCtD
Vinblastine—Hypersensitivity—Epirubicin—liver cancer	4.72e-05	0.00325	CcSEcCtD
Vinblastine—Abdominal pain—Doxorubicin—liver cancer	4.69e-05	0.00323	CcSEcCtD
Vinblastine—Asthenia—Epirubicin—liver cancer	4.6e-05	0.00317	CcSEcCtD
Vinblastine—Diarrhoea—Epirubicin—liver cancer	4.39e-05	0.00302	CcSEcCtD
Vinblastine—Hypersensitivity—Doxorubicin—liver cancer	4.37e-05	0.00301	CcSEcCtD
Vinblastine—Asthenia—Doxorubicin—liver cancer	4.26e-05	0.00293	CcSEcCtD
Vinblastine—Dizziness—Epirubicin—liver cancer	4.24e-05	0.00292	CcSEcCtD
Vinblastine—Vomiting—Epirubicin—liver cancer	4.08e-05	0.00281	CcSEcCtD
Vinblastine—Diarrhoea—Doxorubicin—liver cancer	4.06e-05	0.00279	CcSEcCtD
Vinblastine—Headache—Epirubicin—liver cancer	4.02e-05	0.00276	CcSEcCtD
Vinblastine—Dizziness—Doxorubicin—liver cancer	3.92e-05	0.0027	CcSEcCtD
Vinblastine—Nausea—Epirubicin—liver cancer	3.81e-05	0.00262	CcSEcCtD
Vinblastine—Vomiting—Doxorubicin—liver cancer	3.77e-05	0.0026	CcSEcCtD
Vinblastine—Headache—Doxorubicin—liver cancer	3.72e-05	0.00256	CcSEcCtD
Vinblastine—Nausea—Doxorubicin—liver cancer	3.52e-05	0.00243	CcSEcCtD
Vinblastine—JUN—Immune System—BCL2L1—liver cancer	4.49e-06	6.7e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—CYP2E1—liver cancer	4.47e-06	6.68e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	4.42e-06	6.59e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	4.41e-06	6.58e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—MAPK8—liver cancer	4.38e-06	6.54e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	4.37e-06	6.53e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	4.33e-06	6.46e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—CYP1A1—liver cancer	4.28e-06	6.38e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	4.27e-06	6.38e-05	CbGpPWpGaD
Vinblastine—ABCC2—Transmembrane transport of small molecules—RAF1—liver cancer	4.27e-06	6.37e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PSMA4—liver cancer	4.26e-06	6.36e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PSMD10—liver cancer	4.26e-06	6.36e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—MAPK14—liver cancer	4.25e-06	6.34e-05	CbGpPWpGaD
Vinblastine—ABCB1—Transmembrane transport of small molecules—CYCS—liver cancer	4.25e-06	6.34e-05	CbGpPWpGaD
Vinblastine—ABCC1—Transmembrane transport of small molecules—RAF1—liver cancer	4.22e-06	6.29e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—CYCS—liver cancer	4.19e-06	6.25e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	4.17e-06	6.22e-05	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle—TP53—liver cancer	4.15e-06	6.19e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—GOT2—liver cancer	4.14e-06	6.18e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—UGDH—liver cancer	4.12e-06	6.15e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—GGT1—liver cancer	4.11e-06	6.13e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—GOT1—liver cancer	4.11e-06	6.13e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Transmembrane transport of small molecules—ALB—liver cancer	4.06e-06	6.06e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CPT1B—liver cancer	4.05e-06	6.05e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GLUL—liver cancer	4.05e-06	6.05e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—MTHFR—liver cancer	3.99e-06	5.95e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—H2AFX—liver cancer	3.94e-06	5.89e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PPARA—liver cancer	3.91e-06	5.84e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—NR1H4—liver cancer	3.91e-06	5.83e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—CYP2E1—liver cancer	3.9e-06	5.81e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—EPT1—liver cancer	3.87e-06	5.78e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	3.85e-06	5.75e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GSTA3—liver cancer	3.84e-06	5.73e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PRKCE—liver cancer	3.84e-06	5.73e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GLUL—liver cancer	3.82e-06	5.7e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CPT1B—liver cancer	3.82e-06	5.7e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Neuronal System—HRAS—liver cancer	3.76e-06	5.61e-05	CbGpPWpGaD
Vinblastine—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	3.7e-06	5.51e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—GSTP1—liver cancer	3.69e-06	5.51e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—NR1H4—liver cancer	3.68e-06	5.49e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Transmembrane transport of small molecules—RAF1—liver cancer	3.67e-06	5.48e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—TAT—liver cancer	3.67e-06	5.48e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—CYCS—liver cancer	3.64e-06	5.44e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—HMOX1—liver cancer	3.64e-06	5.43e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—IGF2—liver cancer	3.64e-06	5.42e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—CDH1—liver cancer	3.63e-06	5.41e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GSTA3—liver cancer	3.62e-06	5.4e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—MTHFR—liver cancer	3.58e-06	5.34e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—GOT1—liver cancer	3.58e-06	5.34e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—GGT1—liver cancer	3.58e-06	5.34e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—TERT—liver cancer	3.57e-06	5.32e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	3.54e-06	5.29e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	3.53e-06	5.28e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.51e-06	5.24e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GSTA4—liver cancer	3.51e-06	5.24e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—PIK3CD—liver cancer	3.47e-06	5.17e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—KRAS—liver cancer	3.44e-06	5.14e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GSTA2—liver cancer	3.42e-06	5.11e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CSF2—liver cancer	3.39e-06	5.07e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—GSTM1—liver cancer	3.39e-06	5.06e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PIK3CG—liver cancer	3.35e-06	5e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—H2AFX—liver cancer	3.35e-06	4.99e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GSTA4—liver cancer	3.31e-06	4.94e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GSTA1—liver cancer	3.3e-06	4.93e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	3.3e-06	4.93e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	3.27e-06	4.89e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—NAT2—liver cancer	3.27e-06	4.87e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PPARG—liver cancer	3.23e-06	4.83e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GSTA2—liver cancer	3.23e-06	4.81e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—CYP1A1—liver cancer	3.21e-06	4.8e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—GSTP1—liver cancer	3.21e-06	4.79e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—HMOX1—liver cancer	3.17e-06	4.73e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—PIK3CA—liver cancer	3.16e-06	4.72e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—ALDOB—liver cancer	3.13e-06	4.67e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GSTA1—liver cancer	3.11e-06	4.64e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—RAF1—liver cancer	3.09e-06	4.62e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—NAT2—liver cancer	3.08e-06	4.59e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—TERT—liver cancer	3.03e-06	4.52e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—MTOR—liver cancer	3.02e-06	4.51e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—PIK3CB—liver cancer	3.02e-06	4.51e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	3.01e-06	4.49e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—APC—liver cancer	3.01e-06	4.49e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—MTHFR—liver cancer	3e-06	4.47e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CRABP1—liver cancer	2.99e-06	4.46e-05	CbGpPWpGaD
Vinblastine—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	2.99e-06	4.46e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—GSTM1—liver cancer	2.95e-06	4.41e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ALDOB—liver cancer	2.95e-06	4.4e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PIK3CD—liver cancer	2.95e-06	4.4e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PPARA—liver cancer	2.94e-06	4.39e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—HRAS—liver cancer	2.93e-06	4.37e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	2.91e-06	4.34e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—ALB—liver cancer	2.91e-06	4.34e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—CDKN1B—liver cancer	2.84e-06	4.23e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—BRAF—liver cancer	2.83e-06	4.22e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CRABP1—liver cancer	2.81e-06	4.2e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—IL6—liver cancer	2.8e-06	4.18e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—CYP1A1—liver cancer	2.8e-06	4.18e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—IL2—liver cancer	2.77e-06	4.14e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—KDR—liver cancer	2.77e-06	4.13e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MAPK14—liver cancer	2.75e-06	4.1e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—ESR1—liver cancer	2.7e-06	4.02e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—CTNNB1—liver cancer	2.68e-06	4e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—F2—liver cancer	2.66e-06	3.98e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PIK3CD—liver cancer	2.64e-06	3.94e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.64e-06	3.94e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—CDKN1A—liver cancer	2.62e-06	3.9e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—SERPINE1—liver cancer	2.61e-06	3.9e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—HPGDS—liver cancer	2.61e-06	3.9e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—MTHFR—liver cancer	2.61e-06	3.89e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—AKT1—liver cancer	2.58e-06	3.85e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PIK3CB—liver cancer	2.57e-06	3.83e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PPARA—liver cancer	2.56e-06	3.82e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—MAPK8—liver cancer	2.55e-06	3.81e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PIK3CG—liver cancer	2.55e-06	3.8e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—APC—liver cancer	2.55e-06	3.8e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PIK3CG—liver cancer	2.52e-06	3.76e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CPT1B—liver cancer	2.5e-06	3.72e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GLUL—liver cancer	2.5e-06	3.72e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—HPGDS—liver cancer	2.46e-06	3.67e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	2.46e-06	3.67e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PPARG—liver cancer	2.43e-06	3.63e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—NR1H4—liver cancer	2.41e-06	3.59e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—BRAF—liver cancer	2.4e-06	3.58e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GSTA3—liver cancer	2.37e-06	3.53e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—RAF1—liver cancer	2.36e-06	3.52e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—STAT3—liver cancer	2.33e-06	3.48e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PSMA4—liver cancer	2.33e-06	3.47e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PSMD10—liver cancer	2.33e-06	3.47e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PIK3CB—liver cancer	2.3e-06	3.44e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—MTOR—liver cancer	2.3e-06	3.44e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GOT2—liver cancer	2.26e-06	3.38e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PIK3CD—liver cancer	2.24e-06	3.34e-05	CbGpPWpGaD
Vinblastine—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	2.22e-06	3.31e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—SERPINE1—liver cancer	2.22e-06	3.31e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PIK3CD—liver cancer	2.21e-06	3.3e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PSMA4—liver cancer	2.19e-06	3.27e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PSMD10—liver cancer	2.19e-06	3.27e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PIK3CG—liver cancer	2.19e-06	3.27e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—ALB—liver cancer	2.18e-06	3.26e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GSTA4—liver cancer	2.16e-06	3.23e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—CDKN1B—liver cancer	2.16e-06	3.23e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GOT2—liver cancer	2.13e-06	3.18e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CYP2E1—liver cancer	2.13e-06	3.18e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PPARG—liver cancer	2.12e-06	3.16e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GSTA2—liver cancer	2.11e-06	3.15e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—CTNNB1—liver cancer	2.04e-06	3.05e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GSTA1—liver cancer	2.03e-06	3.04e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—NAT2—liver cancer	2.01e-06	3e-05	CbGpPWpGaD
Vinblastine—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	2.01e-06	2.99e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CYP2E1—liver cancer	2.01e-06	2.99e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—KRAS—liver cancer	2e-06	2.99e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—RAF1—liver cancer	2e-06	2.99e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—CDKN1A—liver cancer	1.99e-06	2.98e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CYCS—liver cancer	1.99e-06	2.97e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GOT1—liver cancer	1.95e-06	2.92e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GGT1—liver cancer	1.95e-06	2.92e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PIK3CB—liver cancer	1.95e-06	2.91e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MTOR—liver cancer	1.95e-06	2.91e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ALDOB—liver cancer	1.93e-06	2.88e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PIK3CB—liver cancer	1.93e-06	2.88e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PIK3CD—liver cancer	1.93e-06	2.88e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—ALB—liver cancer	1.9e-06	2.84e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CYCS—liver cancer	1.88e-06	2.8e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—PIK3CA—liver cancer	1.84e-06	2.75e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GGT1—liver cancer	1.84e-06	2.75e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GOT1—liver cancer	1.84e-06	2.75e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CRABP1—liver cancer	1.84e-06	2.75e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CDKN1B—liver cancer	1.83e-06	2.74e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CASP3—liver cancer	1.8e-06	2.68e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—IL2—liver cancer	1.79e-06	2.68e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—STAT3—liver cancer	1.78e-06	2.66e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GSTP1—liver cancer	1.76e-06	2.62e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CCND1—liver cancer	1.75e-06	2.61e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CTNNB1—liver cancer	1.73e-06	2.58e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—HMOX1—liver cancer	1.73e-06	2.58e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—HRAS—liver cancer	1.7e-06	2.54e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MMP9—liver cancer	1.7e-06	2.53e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CDKN1A—liver cancer	1.69e-06	2.52e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PIK3CB—liver cancer	1.68e-06	2.51e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—MYC—liver cancer	1.65e-06	2.47e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GSTP1—liver cancer	1.65e-06	2.47e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MAPK8—liver cancer	1.65e-06	2.46e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—TGFB1—liver cancer	1.65e-06	2.46e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—HMOX1—liver cancer	1.63e-06	2.43e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—IL6—liver cancer	1.63e-06	2.43e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GSTM1—liver cancer	1.61e-06	2.41e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—HPGDS—liver cancer	1.61e-06	2.4e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PIK3CA—liver cancer	1.57e-06	2.34e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CYP1A1—liver cancer	1.53e-06	2.28e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—KRAS—liver cancer	1.53e-06	2.28e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—VEGFA—liver cancer	1.52e-06	2.28e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GSTM1—liver cancer	1.52e-06	2.27e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—STAT3—liver cancer	1.51e-06	2.25e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—AKT1—liver cancer	1.5e-06	2.25e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CYP1A1—liver cancer	1.44e-06	2.15e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PSMA4—liver cancer	1.43e-06	2.14e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PSMD10—liver cancer	1.43e-06	2.14e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—MTHFR—liver cancer	1.43e-06	2.13e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PIK3CA—liver cancer	1.4e-06	2.1e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MYC—liver cancer	1.4e-06	2.09e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—TGFB1—liver cancer	1.4e-06	2.09e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PPARA—liver cancer	1.4e-06	2.09e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GOT2—liver cancer	1.39e-06	2.08e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—MTHFR—liver cancer	1.34e-06	2e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PPARA—liver cancer	1.32e-06	1.97e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CYP2E1—liver cancer	1.31e-06	1.96e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—HRAS—liver cancer	1.3e-06	1.94e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—KRAS—liver cancer	1.3e-06	1.93e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—AKT1—liver cancer	1.28e-06	1.91e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—IL6—liver cancer	1.24e-06	1.86e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CYCS—liver cancer	1.23e-06	1.83e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GOT1—liver cancer	1.2e-06	1.8e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GGT1—liver cancer	1.2e-06	1.8e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PIK3CG—liver cancer	1.2e-06	1.79e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PIK3CA—liver cancer	1.19e-06	1.78e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PIK3CA—liver cancer	1.18e-06	1.75e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PPARG—liver cancer	1.16e-06	1.72e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—TP53—liver cancer	1.15e-06	1.72e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—AKT1—liver cancer	1.15e-06	1.71e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PIK3CG—liver cancer	1.13e-06	1.68e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—HRAS—liver cancer	1.1e-06	1.64e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PPARG—liver cancer	1.09e-06	1.63e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GSTP1—liver cancer	1.08e-06	1.61e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—HMOX1—liver cancer	1.07e-06	1.59e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—IL6—liver cancer	1.05e-06	1.57e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PIK3CD—liver cancer	1.05e-06	1.57e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—ALB—liver cancer	1.04e-06	1.55e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PIK3CA—liver cancer	1.02e-06	1.53e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GSTM1—liver cancer	9.94e-07	1.48e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PIK3CD—liver cancer	9.92e-07	1.48e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ALB—liver cancer	9.79e-07	1.46e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—AKT1—liver cancer	9.73e-07	1.45e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—AKT1—liver cancer	9.61e-07	1.43e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CYP1A1—liver cancer	9.42e-07	1.41e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PIK3CB—liver cancer	9.18e-07	1.37e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—MTHFR—liver cancer	8.78e-07	1.31e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PIK3CB—liver cancer	8.65e-07	1.29e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PPARA—liver cancer	8.62e-07	1.29e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—AKT1—liver cancer	8.37e-07	1.25e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PIK3CG—liver cancer	7.38e-07	1.1e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PPARG—liver cancer	7.12e-07	1.06e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PIK3CD—liver cancer	6.49e-07	9.68e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ALB—liver cancer	6.4e-07	9.56e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PIK3CB—liver cancer	5.65e-07	8.44e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PIK3CA—liver cancer	5.59e-07	8.35e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PIK3CA—liver cancer	5.27e-07	7.87e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—AKT1—liver cancer	4.57e-07	6.82e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—AKT1—liver cancer	4.31e-07	6.43e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PIK3CA—liver cancer	3.45e-07	5.14e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—AKT1—liver cancer	2.82e-07	4.2e-06	CbGpPWpGaD
